Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.

Goal: To determine the effect of the specific carbohydrate diet (SCD) on active inflammatory bowel disease (IBD).

Background: IBD is a chronic idiopathic inflammatory intestinal disorder associated with fecal dysbiosis. Diet is a potential therapeutic option for IBD based on the hypothesis that changing the fecal dysbiosis could decrease intestinal inflammation.

Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease.

Objective: The aim of the study was to prospectively evaluate clinical and mucosal responses to the specific carbohydrate diet (SCD) in children with Crohn disease (CD).

Methods: Eligible patients with active CD (Pediatric Crohn's Disease Activity Index [PCDAI] ≥ 15) underwent a patency capsule and, if passed intact, capsule endoscopy (CE) was performed. Patients taking SCD were monitored for 52 weeks while maintaining all prescribed medications.

Pediatric capsule endoscopy: review of the small bowel and patency capsules.

Background And Objective: Because capsule endoscopy (CE) avoids ionizing radiation, deep sedation, and general anesthesia, CE may be valuable in pediatrics. We report a single pediatric center's experience with the use and safety of CE.

Methods: In a retrospective review of consecutive CE studies, 284 CE studies were performed in 277 patients with a mean age of 15 (±3.

The use of a patency capsule in pediatric Crohn's disease: a prospective evaluation.

Background: Capsule endoscopy (CE) retention remains a concern in patients with suspected or known Crohn's Disease (CD).

Aim: The aim of this study was to evaluate the ability of a patency capsule (PC) to establish functional patency in pediatric patients with suspected or known, symptomatic IBD.

Methods: A prospective, single center study evaluating the impact of CE on CD management used PC to qualify patients for CE.